New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
04:55 EDTPEP, PEP, F, F, PRGO, PRGO, ROC, ROC, SYMC, SYMC, MS, MS, FRX, FRX, TWC, TWC, JNPR, JNPR, HD, HD, GILD, GILD, CSCO, CSCO, SI, SIWall Street Journal to hold annual meeting
Wall Street Journal CFO Network Annual Meeting to be held in Washington, D.C. on June 16-17.
News For PEP;CSCO;GILD;HD;JNPR;TWC;FRX;MS;SYMC;ROC;PRGO;F;SI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
October 10, 2014
13:42 EDTGILDGilead hepatitis C treatment Harvoni approved by FDA
The FDA announced the approval of Harvoni to treat chronic hepatitis C virus genotype 1 infection. Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection, the agency stated. It is also the first approved regimen that does not require administration with interferon or ribavirin, two FDA-approved drugs also used to treat HCV infection, it added. Harvoni is marketed by Gilead.
13:40 EDTGILDFDA approves Gilead hepatitus C treatment Harvoni
Subscribe for More Information
10:09 EDTJNPRJuniper falls after earnings warning, levels to watch
Shares are down over 6% to $19.68 at time of writing. At that price next support is at $19 and then at $18.56. Resistance is at $20.49.
10:01 EDTSYMCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:08 EDTHDHome Depot management to meet with Deutsche Bank
Subscribe for More Information
09:08 EDTSYMCSymantec upgraded at Raymond James
Subscribe for More Information
09:00 EDTJNPROn The Fly: Pre-market Movers
Subscribe for More Information
08:38 EDTPEPPepsiCo valuation discount vs. peers to close, says Morgan Stanley
Subscribe for More Information
08:19 EDTGILDMedivir announces Janssen initiates enrolment in phase II IMPACT study
Subscribe for More Information
08:17 EDTSYMCSymantec split unlikely to create shareholder value, says Pacific Crest
Subscribe for More Information
07:51 EDTSYMCSymantec may face heightened execution risk, says Wells Fargo
Subscribe for More Information
07:47 EDTJNPRJuniper results could rebound in 2015, says Wells Fargo
After Juniper negatively preannounced its Q3 results, Wells Fargo thinks improved carrier spending, continued enterprise share gains and restructuring efforts could enable the company's results to improve in 2015. The firm cut its price target on the stock to $25-$27 from $28-$30. It keeps an Outperform rating on the shares.
07:42 EDTSYMCSymantec upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
07:27 EDTJNPRJuniper price target lowered to $27 from $29 at UBS
UBS lowered its price target on Juniper to $27 from $29 following the company's negative pre-announcement. The company cited lower than anticipated U.S. demand and UBS believes the downside earnings risk is limited by lower operating expenses and lower variable compensation. UBS maintains its Buy rating on Juniper.
07:21 EDTSYMCSymantec price target raised to $30 from $27 at JMP Securities
Subscribe for More Information
07:21 EDTGILDFDA PDUFA Date for Gilead Sciences Sofosbuvir is October 10, 2014
Subscribe for More Information
07:17 EDTFCitigroup and the Society of Automotive Analysts to co-host a summit
Automotive Investor Summit is being held in Southfield, Michigan on October 10.
07:03 EDTJNPRJuniper price target lowered to $25 from $29.50 at Cantor
Cantor cut its price target on Juniper after the company lowered its Q3 guidance. However, the firm keeps a Buy rating on the shares.
06:48 EDTSYMCSymantec volatility low into announcing plans to separate into two companies
Subscribe for More Information
06:44 EDTFFord reports China unit sold 95,875 vehicles in September, Reuters says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use